Hypertension in Saskatchewan

A new study published in the Canadian Pharmacists Journal, shows that comprehensive long-term pharmacist care for Canadians with hyertension, including patient education and prescribing, improves health outcomes and will save money for Saskatchewan and Canada's health care system. For Saskatchewan, there is a potential savings of $423 million dollars. Pharmacists are in a unique position to help contribute to patient-centred care.

The peer-reviewed study looked at alternatives to usual hypertension care, including full scope pharmacist care—making full use of pharmacists’ scope of skills, including prescribing. The analysis shows a real and significant benefit from pharmacist care both in terms of cost savings and health benefits when compared to usual care.

For the full provincial report, see below

Saskatchewan Hypertension Study 

The model presented in the report has an interactive tool which allows users to explore changes in economic and health impacts in different time frames and health scenarios.  

https://models.broadstreetheor.com/CPhA/CEA/index.html#

Simplified version of the app:

https://models.broadstreetheor.com/CPhA/Scenarios/index.html

 

The national report is available below. 

National Hypertension Study

National Study Q & A 

Hypertension Video

Please visit the Canadian Pharmacists Association website for further information on the national report. 

What's New

Membership Matters

The 2019 PAS Membership and Malpractice Renewal is now open. PAS sent out an email last week to members on how they can renew their PAS membership.

More

An Aging Population, Health care and the Role of Pharmacists in Saskatchewan with a National Comparison

The Pharmacy Association of Saskatchewan, in partnership with CPhA, commissions yearly public opinion surveys on public perceptions and attitudes towards pharmacists in Saskatchewan and across Canada.

More

Update on EpiPen® Availability

There is a recent update from Pfizer Canada on EpiPen® and EpiPen Jr® auto-injectors.

More

Joint CPhA/APhA Statement - Drug Importation Policy

The American Pharmacists Association (APhA) and the Canadian Pharmacists Association (CPhA) have issued a joint statement opposing U.S. federal legislation authorizing personal and commercial importation of prescription drugs from Canada.

More
View All